A New Approach to Treating Sleep Apnea
Sleep apnea is a serious sleep disorder in which a person repeatedly stops breathing during the night. Left untreated, it can lead to chronic fatigue, mood disorders, cardiovascular complications, and a reduced quality of life. While traditional treatments like CPAP machines and lifestyle changes remain standard, a new large-scale study from Minnesota suggests medical cannabis may offer significant therapeutic benefits.
What the Study Found
The Minnesota Office of Cannabis Management (OCM) conducted a comprehensive five-year review of patients diagnosed with obstructive sleep apnea and enrolled in the state’s medical cannabis program. Between August 1, 2018, and July 31, 2023, data was collected from 3,102 patients—making it the largest study of its kind in the U.S.
Key findings include:
- 39.4% of participants experienced at least a 30% reduction in symptoms within the first four months of cannabis treatment.
- Of those, 73.6% maintained the improvement for an additional four months or more.
- Among patients reporting moderate to severe fatigue at enrollment, 55.3% reported significant relief.
- Additionally, over one-third of patients with anxiety or depression reported improvement in mental health symptoms while using medical cannabis.
Durable Results Over Time
One of the most promising aspects of the study is not just the speed of symptom improvement, but its sustainability. The majority of patients who experienced better sleep or reduced fatigue were able to maintain those benefits for at least eight months.
In patients who started with moderate to severe sleep disturbance, 60.8% saw significant improvement within four months. The durability of the response suggests medical cannabis may offer not just short-term relief but long-term support for chronic sleep issues.
What Makes Minnesota’s Program Unique
Unlike most U.S. states with legalized medical cannabis, Minnesota is legally required to track patient outcomes and conduct research based on real-world data. This ensures the program is driven by evidence and patient experience, allowing for ongoing evaluation of cannabis as a medical treatment.
By continually gathering data and publishing its findings, Minnesota is building a scientific foundation for cannabis policy and clinical best practices that other states may one day follow.
Cannabis vs Traditional Sleep Aids
Cannabis is quickly becoming a preferred sleep aid among adults. A 2025 industry-backed survey revealed that 16% of Americans aged 21 and older use cannabis to help them sleep—more than those who use prescription medications (12%) or alcohol (11%). Only over-the-counter sleep aids (19%) and supplements like melatonin (26%) rank higher.
As awareness grows, patients are increasingly turning to plant-based treatments with fewer side effects and potentially broader health benefits.
Expert Commentary
Grace Christensen, senior research analyst at OCM, emphasized the significance of the findings:
“These results show meaningful changes in disturbed sleep and fatigue for patients after starting medical cannabis. It points to a broader, holistic benefit in managing chronic sleep disorders.”
OCM also noted that patients who initially reported symptoms of depression and anxiety showed measurable improvement, highlighting the mental health advantages of cannabis therapy in complex cases like sleep apnea.
Related Articles You Might Find Useful
Interested in more medical cannabis research? Explore these articles from our editorial team:
- New Guidelines: How Cannabis Is Changing Cancer Care for Patients in 2025
- Cannabis vs Sedatives: New Study on Cannabis Use in Cancer Patients
- Cannabis Extracts for Autism: Promising Results in Children and Teens
